Patents Assigned to Miltenyi Biotec GmbH
-
Publication number: 20160187326Abstract: The invention is directed to a method for detecting a target moiety in a sample of biological specimens by: a) providing at least one conjugate with the general formula (I) Xn-P-Ym, with X is an detection moiety, P an enzymatically degradable spacer and Y an antigen recognizing moiety and n, m are integers between 1 and 100 and wherein X and Y are covalently bound to P; b) contacting the sample of biological specimens with at least one conjugate, thereby labeling the target moiety recognized by the antigen recognizing moiety Y; c) detecting the target moiety labeled with the conjugate with the detecting moiety X; and d) enzymatically degrading spacer P, thereby cleaving the detection moiety X from the conjugate. The method is useful to identify target moieties on the biological specimens. The biological specimens detected by the conjugate can be subsequently removed from the sample.Type: ApplicationFiled: November 18, 2015Publication date: June 30, 2016Applicant: MILTENYI BIOTEC GMBHInventors: Christian Dose, Jennifer Brieden, Stefan Miltenyi, Thomas Rockel, Veronika Gann
-
Publication number: 20160047809Abstract: The present invention provides the in-vitro use of at least one in-vivo-target antigen of Aspergillus fumigatus for selective activation, detection and/or analysis of Aspergillus fumigatus specific CD4+ T cells in a sample comprising cells, wherein said at least one in-vivo-target antigen reveals an immune reactivity characterized by i) the in vivo existence of antigen-specific T cells comprising more than 60% memory T cells and ii) said antigen-specific T cells further comprise T cells able to produce IFN-gamma upon stimulation at a frequency between 15% and 80% and/or IL17 upon stimulation at a frequency between 5% and 30%. Said at least one in-vivo-target antigen may be selected from the group consisting of antigens Scw4, Pst1, Shm2, GliT and TpiA or fragments thereof. Also provided are a method, a composition, and a kit thereof.Type: ApplicationFiled: August 12, 2015Publication date: February 18, 2016Applicants: MILTENYI BIOTEC GMBH, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoll InstituteInventors: Alexander SCHEFFOLD, Petra BACHER, Olaf KNIEMEYER, Janka TEUTSCHBEIN, Axel BRAKHAGE
-
Publication number: 20160047808Abstract: Object of the invention is a process for depleting host cells from a xenograft of human cells on a murine host characterized in a) fragmenting the xenograft into a sample comprising a single cell suspension b) subjecting the sample to antibodies specific for a murine CD9 epitope coupled to a detection means c) depleting the cell suspension from cells bound by the CD9-antibodies using the detection means d) collecting the cells not bound by the CD9-antibodies as target cells.Type: ApplicationFiled: July 15, 2015Publication date: February 18, 2016Applicant: Miltenyi Biotec GmbHInventors: Andreas Bosio, Olaf Hardt, David Agorku
-
Publication number: 20160017325Abstract: Lipophilic oligonucleotide comprising a phosphate glycerol unit containing at least one aliphatic unsaturated carbon bond according to formula (I), with Oligonucleotide an unmodified or modified nucleic acid of 2-1000 nucleotides in length R=a bond or a linker unit Y?OH, SH or NHR3 X and Z=independently O, S or NR3 R3=hydrogen or branched or unbranched and/or substituted or unsubstituted alkyl, aryl and/or alkyl aryl residue with 10 to 30 carbon atoms R1, R2 branched or unbranched and/or substituted or unsubstituted alkyl, aryl and/or alkylaryl residue with 10 to 30 carbon atoms, with the provisio that at least one of the residues R1 or R2 comprises at least one aliphatic carbon-carbon double bond Use of lipophilic oligonucleotide according to Formula I for drug discovery or for transfection of cells.Type: ApplicationFiled: March 18, 2014Publication date: January 21, 2016Applicant: MILTENYI BIOTEC GMBHInventors: Dr. Eugen ULLMANN, Dr. Romualdus SMICIUS, Dr. Thomas ROCKEL
-
Publication number: 20150344832Abstract: The invention is directed to a homogenization device for cell suspensions, comprising a first rotating magnet; a shaft on which a propeller mixer is attached which rotates around the longitudinal axis of the shaft and is movable in lateral direction of the axis of the shaft; the propeller mixer being provided with at least two propeller blades of which at least one is provided with a second magnet; wherein the propeller mixer is rotated by magnetic interaction of the second magnet with the first rotating magnet.Type: ApplicationFiled: May 26, 2015Publication date: December 3, 2015Applicant: Miltenyi Biotec GmbHInventors: Jan Boddenberg, Stefan MILTENYI, Frederick Fritzsch
-
Publication number: 20150328605Abstract: The invention is related to a device for suspending particles in a fluid, wherein the mixing device includes a first magnet (1) rotating around a longitudinal axis (2), a mixing rod (4) attached to a mount (6), the mount including a second magnet (3), wherein the mount (6) moves in a substantially orthogonal motion to the longitudinal axis of the mixing rod (4) by the interaction of the rotating first magnet with the second magnet (3).Type: ApplicationFiled: May 6, 2015Publication date: November 19, 2015Applicant: Miltenyi Biotec GmbHInventors: Dominik Hammerschmidt, Sven Ignatius, Martin Buscher, Ralf-Peter Peters
-
Publication number: 20150307900Abstract: The invention relates to a process for generation of genetically modified stem cells comprising the steps a) providing a cell sample in suspension comprising stem cells in a centrifugation chamber comprising a base plate and cover plate connected by a cylinder b) adjusting the volumetric concentration of stem cells in the cell sample to at least 1×105 stem cells per mL cell sample by centrifugation c) introducing viral and/or non-viral vectors to the centrifugation chamber for genetically modifying the stem cells d) adjusting the spatial concentration of stem cells in the centrifugation chamber by rotating the centrifugation chamber at a speed where the cell sample is located at the outermost 35% of the radius of the base plate of the centrifugation chamber, thereby inducing gene modification of the stem cells.Type: ApplicationFiled: April 17, 2015Publication date: October 29, 2015Applicant: MILTENYI BIOTEC GMBHInventors: Ian Johnston, Volker Huppert, Michael Essl, Stefan MILTENYI
-
Patent number: 9133263Abstract: The invention relates to a cell containing a gene encoding a conditional transgenic surface marker that is detectable upon expression on the surface of the cell, wherein the gene encoding a conditional transgenic surface marker comprises: (i) a promoter, operably linked to (ii) a first transcription sequence, and (iii) a second transcription sequence encoding the surface marker, whereby the first transcription sequence prevents the transcription of the second transcription sequence, whereby the first transcription sequence is conditionally removable such that the second transcription sequence is transcribable, and whereby the surface marker renders the cell sortable through the detection of the conditional transgenic surface marker. Furthermore, the invention relates to a construct for generating such a cell, and to a method for separating such a cell from a population of cells.Type: GrantFiled: November 20, 2008Date of Patent: September 15, 2015Assignee: MILTENYI BIOTEC GMBHInventor: Andreas Bosio
-
Patent number: 9080149Abstract: The present invention provides the use of the cell surface antigen CD51 as a negative selection marker for neuronal cells and a method for enrichment, isolation and/or detection of neuronal cells comprising the steps a) contacting a sample containing neuronal cells with an antigen-binding fragment specific for the CD51 antigen coupled to a solid phase, thereby labeling the CD51 positive cells of said sample and b) isolating the non-labeled cells of said sample.Type: GrantFiled: February 27, 2013Date of Patent: July 14, 2015Assignee: Miltenyi Biotec GmbHInventors: Andreas Bosio, Melanie Jungblut
-
Patent number: 9073051Abstract: A heating device for single cylindrical laboratory vessels (e.g., laboratory test tubes), the heating device including a clamp-like element using a force-fit to encompass at least a part of each cylindrical laboratory vessel, one or more electrical resistance heating circuits located at the interior of the clamp-like element, and grab handles to open and close the clamp-like element, thereby to insert or release the cylindrical laboratory vessel from the heating device.Type: GrantFiled: January 6, 2012Date of Patent: July 7, 2015Assignee: Miltenyi Biotec GmbHInventors: Jürgen Schulz, Franz Bucher, Eiad Kabaha
-
Publication number: 20150017714Abstract: The invention is directed to a centrifuge chamber comprising a cylinder having a base plate and a cover plate, a rotational axis with at least one port for input and/or output of liquids, at least one port for input of gases and at least one layer for cell culturing, wherein the layer for cell culturing comprises a gas-permeable membrane on which cells can be cultured and wherein the at least one port for input and/or output of gases is connected to the gas-permeable membrane.Type: ApplicationFiled: June 23, 2014Publication date: January 15, 2015Applicant: MILTENYI BIOTEC GMBHInventors: Eiad Kabaha, Stefan Miltenyi, Ralf-Peter Peters
-
Publication number: 20140315311Abstract: The invention relates to a cell modification device, comprising a centrifugation chamber with at least one cell modifying surface with a normal vector having an angle of 135-45° to the rotational axis of the centrifugation chamber, wherein the centrifugation chamber comprises at least one input/output port and the cells to be modified are immobilized at the cell modifying surfaces by the rotation of the centrifugation chamber at 2 to 2000 g.Type: ApplicationFiled: November 13, 2012Publication date: October 23, 2014Applicant: MILTENYI BIOTEC GMBHInventors: Stefan Miltenyi, Alexander Scheffold
-
Publication number: 20140212961Abstract: The invention relates to a centrifuge for separating a sample into at least two components, comprising a chamber for receiving a sample to be centrifuged. According to the invention, the centrifuge further comprises a means for controlling the progress of the sample separation is located at the chamber.Type: ApplicationFiled: March 7, 2014Publication date: July 31, 2014Applicant: Miltenyi Biotec GmbHInventors: Stefan Miltenyi, Winfried Schimmelpfennig, Holger Lantow, Niklas Elmar Neuschafer, Martin Biehl, Eiad Kabaha, Jürgen Schulz
-
Patent number: 8765922Abstract: A method and associated device for enrichment of Neél-magnetic particles from a dispersion of Brown-magnetic particles and Neél-magnetic particles. The device and method use ferromagnetic separation particles having a mean diameter of 100 to 250 ?m located in a alternating magnetic field. The ferromagnetic separation particles have a magnetically and chemically inert coating.Type: GrantFiled: October 19, 2011Date of Patent: July 1, 2014Assignee: Miltenyi Biotec GmbHInventors: Jürgen Schulz, Daniel Michalek, Dirk Merkel, Stefan Miltenyi
-
Patent number: 8747290Abstract: The invention relates to a centrifuge for separating a sample into at least two components, comprising a chamber for receiving a sample to be centrifuged. According to the invention, the centrifuge further comprises a means for controlling the progress of the sample separation is located at the chamber.Type: GrantFiled: December 8, 2008Date of Patent: June 10, 2014Assignee: Miltenyi Biotec GmbHInventors: Stefan Miltenyi, Winfried Schimmelpfennig, Holger Lantow, Niklas Elmar Neuschäfer, Martin Biehl, Eiad Kabaha, Jürgen Schulz
-
Patent number: 8727132Abstract: The invention relates to a system, comprising: a) a sample processing unit, comprising an input port and an output port coupled to a rotating container having at least one sample chamber, the sample processing unit configured provide a first processing step to a sample or to rotate the container so as to apply a centrifugal force to a sample deposited in the chamber and separate at least a first component and a second component of the deposited sample; and b) a sample separation unit coupled to the output port of the sample processing unit, the cell separation unit comprising separation column holder (42), a pump (64) and a plurality of valves (1-11) configured to at least partially control fluid flow through a fluid circuitry and a separation column (40) positioned in the holder, the separation column configured to separate labeled and unlabeled components of sample flowed through the column.Type: GrantFiled: December 8, 2008Date of Patent: May 20, 2014Assignee: Miltenyi Biotec GmbHInventors: Stefan Miltenyi, Winfried Schimmelpfennig, Holger Lantow, Elmar Niklas Neuschäfer, Martin Biehl, Eiad Kabaha, Jürgen Schulz
-
Publication number: 20140113315Abstract: The invention is directed to a releasable conjugate comprising a biotinylated ligand having a biotin moiety, a ligand moiety (Ligand1) and a biotin-binding molecule (bbm) bound to the biotin moiety of the biotinylated ligand. The ligand moiety of the biotinylated ligand may be separated by a spacer group consisting of polyethylene glycol. Furthermore, the invention relates to a method for cleaving the releasable conjugate by providing biotin or streptavidin and an auxiliary release agent in a sufficient concentration to displace the biotin-binding molecule (bbm) from the biotin moiety of the biotinylated ligand and a method for separation of target cells from a cell sample utilizing the conjugate.Type: ApplicationFiled: October 2, 2013Publication date: April 24, 2014Applicant: Miltenyi Biotec GmbHInventors: Jennifer Brieden, Christian Dose
-
Publication number: 20140087462Abstract: The present invention provides a method polyclonal stimulation of T cells, the method comprising contacting a population of T cells with a nanomatrix, the nanomatrix comprising a) a flexible matrix, wherein said matrix is of polymeric material; and b) attached to said polymeric flexible matrix one or more polyclonal stimulatory agents which provide activation signals to the T cells; thereby activating and inducing the T cells to proliferate; wherein the nanomatrix is 1 to 500 nm in size. At least one first and one second stimulatory agents are attached to the same or to separate flexible matrices. If the stimulatory agents are attached to separate beads, fine-tuning of nanomatrices for the stimulation of the T cells is possible.Type: ApplicationFiled: September 24, 2013Publication date: March 27, 2014Applicant: Miltenyi Biotec GmbHInventors: Alexander SCHEFFOLD, Mario ASSENMACHER
-
Publication number: 20140073007Abstract: The present invention provides a polynucleotide and a method for screening and enriching a recombinant protein expressed in a eukaryotic cell, the polynucleotide comprising a tricistronic expression cassette comprising a) a promoter, b) a gene of interest (GOI), c) a reporter gene, d) a selection marker gene, e) an internal ribosome entry site (IRES) element, and f) a 2A element. Said method comprises a) transfecting or transducing suitable eukaryotic host cells with the polynucleotides of the present invention, b) culturing the eukaryotic host cells under conditions so as to express the protein of interest, the reporter protein and the selection marker protein in a cell culture selection medium suitable for selecting positively-transfected/transduced cells by means of said selection marker, and c) screening, sorting and/or enriching the cells expressing high levels of protein of interest by means of the reporter protein.Type: ApplicationFiled: August 20, 2013Publication date: March 13, 2014Applicant: Miltenyi Biotec GmbHInventors: Anne SCHÜLER, Nicole Susann ECKARDT, Iris BÜRGER
-
Patent number: 8663985Abstract: An anchoring/capturing system for selecting or analyzing a CHO cell according to a product secreted by the CHO cell is described. The anchoring/capturing system comprises a first antibody or a first antigen-binding fragment for anchoring to the extracellular surface of the CHO cell, and a second antibody or a second antigen-binding fragment for binding the secreted product. Uses and methods involving the anchoring/capturing system are provided.Type: GrantFiled: May 2, 2011Date of Patent: March 4, 2014Assignee: Miltenyi Biotec GmbHInventors: Stefan Miltenyi, Susanne Hoher-Peters, Monika Winkels